Integrated single-cell and bulk RNA sequencing analyses identify a myeloid state-related gene signature for molecular subtyping in stomach adenocarcinoma - Top-Institutions - MDSpire

Integrated single-cell and bulk RNA sequencing analyses identify a myeloid state-related gene signature for molecular subtyping in stomach adenocarcinoma

  • By

  • Ruinan Li

  • Bohong Wei

  • Bin Sun

  • Mingji Li

  • Yingman Wang

  • Xiangyu Zhao

  • Yuntao Yao

  • Duowu Zou

  • Zirui He

  • July 16, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber/Harvard Cancer Center
    Dana-Farber/Harvard Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Princess Margaret Cancer Centre
    Princess Margaret Cancer Centre

    Toronto, Ontario

    Key Differentiators

    • Oncology

  • #4

    University of Toronto
    University of Toronto

    Toronto, Ontario

    Key Differentiators

    • Oncology

  • #5

    Asian Cancer Research Group (ACRG)
    Asian Cancer Research Group (ACRG)

    Singapore, Singapore

    Key Differentiators

    • Oncology

Original Source(s)

Integrated single-cell and bulk RNA sequencing analyses identify a myeloid state-related gene signature for molecular subtyping in stomach adenocarcinoma

  • by Ruinan Li, Bohong Wei, Bin Sun, Mingji Li, Yingman Wang, Xiangyu Zhao, Yuntao Yao, Duowu Zou, Zirui He

  • July 16, 2026

Related Content

Robot-Assisted Surgery for Gastroesophageal Cancers is Transforming Patient Outcomes

Robot-assisted surgery (RAS) has led to shorter hospital stays, faster recovery and reduced pain for patients with many types of cancer. Now, thanks to the pioneering work of Moshim Kukar, MD, FACS, Department of Surgical Oncology, and his Roswell Park team, RAS is the standard of care for eligible patients with gastroesophageal junction cancers.

  • July 27, 2021

  • 1 min
Trends in liver failure-related mortality among middle-aged and older adults with digestive system malignant tumors in the United States, 1999–2023

Assessment of Global Incidence and Risk Factors for Esophageal, Gastric, and Colorectal Cancers in Adolescents and Young Adults: Insights from the 2021 Global Burden of Disease Study